Neurodiagnostics Market Size, Demand and Trends Analysis 2035
According to our forecast, the neurodiagnostics market is expected to grow from USD 20.68 billion in 2026 to USD 43.27 billion by 2035, driven by the rising prevalence of neurological disorders and the expanding use of AI-powered diagnostic technologies. The analysis identifies neuroimaging technologies and hospitals and clinics as the leading segments, while in vitro diagnostics and imaging centers are poised for faster growth. North America currently leads the market due to its advanced healthcare infrastructure, whereas Asia Pacific is emerging as the fastest-growing region. Major companies including Canon Medical Systems, Siemens Healthineers, Philips, Thermo Fisher Scientific, FUJIFILM, and Natus Medical continue to strengthen the competitive landscape through innovation, strategic collaborations, and advanced neurodiagnostic solutions.
Last Updated : 09 September 2026
Category: Diagnostics
Insight Code: 6745
Format: PDF / PPT / Excel